AMBOSS

AMBOSS is a medical knowledge platform for physicians, medical students and other health care professionals, combining editorially produced medical content with AI-supported technology to deliver information at the point of care. The product supports both medical education (including exam preparation and question banks) and clinical decision-making, providing recommendations on diagnostics and treatment based on current guidelines. The company describes the platform as a digital co-pilot for everyday clinical practice, intended to save time and reduce treatment errors.

The offering originated as a German-language product for medical students, later extended to a pre-clinical and physician product for German-speaking markets, and then to an English-language product for the US market covering both students and clinicians. Following acquisitions in 2024, the portfolio also includes nursing-focused content and a board exam preparation product for US residents. Content is produced in-house by medical experts working alongside technology specialists; the team includes scientists, software engineers and more than 150 physicians.

Founding story

AMBOSS was founded in 2012 in Cologne by a group of young residents/physicians who were frustrated by the fragmented state of medical education resources, where the multitude of unconnected materials meant more time spent researching topics than mastering them. They built their own resource, and within a year 95% of future doctors in Germany preparing for final exams were reported to be using it. The team subsequently concluded that information overload affected practicing physicians as well as students, and beyond Germany.

Business model

AMBOSS operates a subscription-style digital knowledge platform serving individual medical students and physicians as well as institutional customers such as hospital groups, with content created in-house by medical experts and delivered through AI-supported software. Growth is supplemented by acquisitions of adjacent products, such as nursing education and US board exam preparation.

Traction

The company reports over 1 million professional users across more than 180 countries as of March 2025; earlier careers-site material cites two million registered medical professionals in over 170 countries. Headcount has grown from 100 employees (2015-2017) to 250 (2017-2019) to over 500 employees from more than 50 countries, including 150+ physicians.

Latest developments

In March 2025 AMBOSS announced the close of a €240M financing round with new primary investors KIRKBI, M&G Investments and Lightrock alongside existing shareholders, after converting to a European stock corporation (SE). Management stated proceeds would fund technology investment, new market segments including nurses and other health care professionals, exploration of additional international markets, and selective acquisitions, with investors described as evergreen funds prepared to remain through a possible IPO.